healthday6 小时
TACE + Lenvatinib, Pembrolizumab Tied to Improved Survival in Unresectable Liver Cancer
For patients with unresectable, nonmetastatic hepatocellular carcinoma, transarterial chemoembolization (TACE) with ...
Combination treatment for liver cancer significantly improves progression-free survival in ...
Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).
An international study led by Hospital Clínic of Barcelona improves the treatment of liver ...
A new drug combination extends by 46% the time that liver cancer remains stable, according to an international clinical trial ...
El País in English7 天
Three-pronged treatment improves prognosis for inoperable liver cancer
Two independent studies reveal that disease progression is delayed by combining two targeted therapies with the traditional ...
Armed robbery in Revesby6 天
Liver Cancer Treatment Breakthrough in Global Study
Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).